Submit Deal

Submit Deal

Cover Image David Bredt

David Bredt

Founder and Chief Scientific Officer at RAPPORT THERAPEUTICS INC

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£83M

Avg. Deal Size£83M

Market Context

Expertise (1)

Key Relationships

Sort

Private EquityPrivateAcquisitionVenture CapitalDomesticMinority

Rapport Therapeutics

target

Rapport Therapeutics

Third Rock Ventures

bidder

Third Rock Ventures

£83m

6 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.